CMMB Chemomab Therapeutics
- 2.130
- 0.0000.00%
- 2.130
- 0.0000.00%
Chemomab Therapeutics News
Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Chemomab Therapeutics | 20-F: FY2023 Annual Report
Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Chemomab Therapeutics | 8-K: Chemomab Therapeutics Announces First Quarter 2023 Financial Results and Provides a Corporate Update
Chemomab Therapeutics | 10-Q: Q1 2023 Earnings Report
Chemomab Therapeutics | 10-K: FY2022 Annual Report
Chemomab Therapeutics | 10-Q: Q3 2022 Earnings Report
Chemomab Therapeutics | 10-Q: Q2 2022 Earnings Report
Chemomab Therapeutics | 8-K: Chemomab Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update
Chemomab Therapeutics | 10-Q: Q1 2022 Earnings Report
Chemomab Therapeutics | 10-K: Annual report
Chemomab Therapeutics | 8-K: Chemomab Therapeutics Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update
No Data
